Absynth Biologics' Series A - II Round

Absynth Biologics raised a round of funding on December 02, 2015. Investors include BioCity Group.

Absynth Biologics has been created with the initial goal of developing immunological prophylaxis and therapy to combat bacterial infections. Absynth's strategy is to exploit the characterization of ca…

Articles about Absynth Biologics' Series A - II Round: